Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00579
|
|||||
Drug Name |
Dihydroergocristine
|
|||||
Synonyms |
Nehydrin
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Alcohol use disorders [ICD11: 6C40] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C35H41N5O5
|
|||||
Canonical SMILES |
CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C
|
|||||
InChI |
InChI=1S/C35H41N5O5/c1-20(2)34(37-31(41)23-16-25-24-11-7-12-26-30(24)22(18-36-26)17-27(25)38(3)19-23)33(43)40-28(15-21-9-5-4-6-10-21)32(42)39-14-8-13-29(39)35(40,44)45-34/h4-7,9-12,18,20,23,25,27-29,36,44H,8,13-17,19H2,1-3H3,(H,37,41)
|
|||||
InChIKey |
DEQITUUQPICUMR-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 17479-19-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 611.7 | Topological Polar Surface Area | 118 | ||
Heavy Atom Count | 45 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | |||
XLogP |
3.3
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
ChEBI ID |
CHEBI:59912
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Dihydroergocristine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. J Pharmacol Exp Ther. 2002 Oct;303(1):323-32. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.